Ampio Pharmaceuticals (AMPE) Shares Gap Up to $0.54

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $0.51, but opened at $0.54. Ampio Pharmaceuticals shares last traded at $0.61, with a volume of 44343 shares traded.

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) last released its quarterly earnings data on Tuesday, August 14th. The specialty pharmaceutical company reported $0.05 earnings per share for the quarter.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers acquired a new position in shares of Ampio Pharmaceuticals during the 2nd quarter worth approximately $154,000. Schwab Charles Investment Management Inc. acquired a new position in shares of Ampio Pharmaceuticals during the 2nd quarter worth approximately $326,000. Bank of New York Mellon Corp increased its position in shares of Ampio Pharmaceuticals by 290.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 202,590 shares of the specialty pharmaceutical company’s stock worth $446,000 after purchasing an additional 150,664 shares during the last quarter. Courier Capital LLC increased its position in shares of Ampio Pharmaceuticals by 2,032.7% during the 3rd quarter. Courier Capital LLC now owns 304,973 shares of the specialty pharmaceutical company’s stock worth $155,000 after purchasing an additional 290,673 shares during the last quarter. Finally, Valeo Financial Advisors LLC acquired a new position in shares of Ampio Pharmaceuticals during the 2nd quarter worth approximately $155,000.

TRADEMARK VIOLATION NOTICE: This article was published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://sportsperspectives.com/2018/11/10/ampio-pharmaceuticals-ampe-shares-gap-up-to-0-54.html.

About Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability.

Featured Story: Stop Order

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply